Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials

With the current landscape of approved therapies for heart failure (HF), there is a need to determine the role of a standard background therapy against which novel therapies are studied. The Heart Failure Collaboratory convened a multistakeholder group of clinical investigators, clinicians, patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiuzat, Mona, Hamo, Carine E., Butler, Javed, Abraham, William T., DeFilippis, Ersilia M., Fonarow, Gregg C., Lindenfeld, Joann, Mentz, Robert J., Psotka, Mitchell A., Solomon, Scott D., Teerlink, John R., Vaduganathan, Muthiah, Vardeny, Orly, McMurray, John J.V., O’Connor, Christopher M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180686/
https://www.ncbi.nlm.nih.gov/pubmed/35115106
http://dx.doi.org/10.1016/j.jacc.2021.11.033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180686/
https://www.ncbi.nlm.nih.gov/pubmed/35115106
http://dx.doi.org/10.1016/j.jacc.2021.11.033

Ejemplares similares